SEARCH

Select one or more sections to restrict the results to these.

Select an author to restrict the results to this.

Previous clinical studies have shown a promising role of fecal microbiota transplantation to induce remission in ulcerative colitis and maintain steroid-induced Crohn’s disease remission. A new double-blind, placebo-controlled trial found fecal microbiota transplantation is not effective at inducing clinical or endoscopic remission in adults with Crohn’s disease.

Vaccines have been protecting us from infectious diseases for over 200 years. Interestingly, recent research suggests unexpected players may be at work behind the scenes: the trillions of microbes that comprise our gut microbiota. Researchers continue to explore how gut microbiota influence immunity, why vaccine responses vary, and whether diet and prebiotics can tip the balance in our favour.

The 6th biennial meeting of the European Society of Neurogastroenterology and Motility, held at Queen Mary University of London, UK, from 4-6 September 2025, covered basic, translational, and clinical research in neurogastroenterology, including dietary therapies and ‘biotics’ for the management of gastrointestinal disorders. Find out more about the main takeaways from the conference.

Fermented foods have been gaining attention in research and on people’s tables due to their link with gut health. More than tradition or flavor, they attract interest as they can influence the gut microbiota and generate compounds with potentially beneficial effects on the body.

Digestive Disease Week 2025 featured recent basic, translational, and clinical research into the microbiome. Find out more about the main takeaways relevant for your clinical practice selected by GMFH editors.

Go to Top